Skip to main content
. 2020 Aug 24;10(8):e039332. doi: 10.1136/bmjopen-2020-039332

Table 3.

Multinomial regression model to assess factors associated with treatment decisions for upper respiratory tract infections (URTIs) with respect to antibiotic use among Chinese university students (n=2834)

Did not treat or self-treated without antibiotics (n=1662, 58.65%) Self-medicated with antibiotics (n=462, 16.30%)‡ Sought formal care (n=710, 25.05%)‡ P value*‡
n (%) n (%) RRR (95% CI) aRRR (95% CI)† n (%) RRR (95% CI) aRRR (95% CI)†
Knowledge about antibiotics
AMR awareness 0.006


 Low 84 (5.05) 23 (4.98) Reference Reference 74 (10.42) Reference Reference
 Medium 302 (18.17) 94 (20.35) 1.14 (0.68 to 1.90) 1.34 (0.77 to 2.34) 175 (24.65) 0.66 (0.46 to 0.95) 0.80 (0.54 to 1.18)
 High 1276 (76.77) 345 (74.68) 0.99 (0.61 to 1.59) 1.38 (0.82 to 2.33) 461 (64.93) 0.41 (0.29 to 0.57) 0.61 (0.42 to 0.89)
Ability to identify antibiotics 0.49


 Low 488 (29.36) 108 (23.38) Reference Reference 210 (29.58) Reference Reference
 Medium 718 (43.20) 224 (48.48) 1.41 (1.09 to 1.82) 1.08 (0.82 to 1.43) 325 (45.77) 1.05 (0.85 to 1.30) 1.08 (0.86 to 1.36)
 High 456 (27.44) 130 (28.14) 1.29 (0.97 to 1.71) 1.20 (0.87 to 1.67) 175 (24.65) 0.89 (0.70 to 1.13) 1.27 (0.97 to 1.66)
Perceived severity of the infection
Common cold is self-limiting <0.0001

 Yes 1216 (73.16) 297 (64.29) Reference Reference 414 (58.31) Reference Reference
 No/I don’t know 446 (26.84) 165 (35.71) 1.51 (1.22 to 1.89) 1.34 (1.05 to 1.71) 296 (41.69) 1.95 (1.62 to 2.34) 1.66 (1.36 to 2.02)
Perceived antibiotic efficacy
Perceived antibiotic efficacy for URTIs <0.0001


 No/low 664 (39.95) 90 (19.48) Reference Reference 184 (25.92) Reference Reference
 Medium 813 (48.92) 267 (57.79) 2.42 (1.87 to 3.14) 1.99 (1.50 to 2.64) 396 (55.77) 1.76 (1.44 to 2.15) 1.46 (1.17 to 1.82)
 High 185 (11.13) 105 (22.73) 4.19 (3.02 to 5.80) 3.03 (2.10 to 4.38) 130 (18.31) 2.54 (1.92 to 3.35) 1.89 (1.38 to 2.57)
Antibiotics are anti-inflammatory drugs 0.02

 No 1123 (67.57) 249 (53.90) Reference Reference 427 (60.14) Reference Reference
 Yes/I don’t know 539 (32.43) 213 (46.10) 1.78 (1.44 to 2.20) 1.40 (1.10 to 1.77) 283 (39.86) 1.38 (1.15 to 1.66) 1.12 (0.91 to 1.38)
Cues to action
Severity of current infection (number of symptoms experienced) <0.001


 Low (one symptom) 974 (58.60) 217 (46.97) Reference Reference 297 (41.83) Reference Reference
 Medium (two symptoms) 507 (30.51) 152 (32.90) 1.35 (1.07 to 1.70) 1.30 (1.01 to 1.68) 234 (32.96) 1.51 (1.24 to 1.85) 1.29 (1.04 to 1.61)
 High (three symptoms or more) 181 (10.89) 93 (20.13) 2.31 (1.73 to 3.08) 1.96 (1.36 to 2.84) 179 (25.21) 3.24 (2.54 to 4.14) 1.64 (1.21 to 2.21)
Fever <0.0001

 No 1432 (86.16) 359 (77.71) Reference Reference 444 (62.54) Reference Reference
 Yes 230 (13.84) 103 (22.29) 1.79 (1.38 to 2.32) 1.23 (0.89 to 1.72) 266 (37.46) 3.73 (3.04 to 4.58) 2.98 (2.32 to 3.83)
Barriers/access to antibiotics
Keeping antibiotics at home <0.0001

 No 628 (37.79) 38 (8,23) Reference Reference 234 (32.96) Reference Reference
 Yes 1034 (62.21) 424 (91.77) 6.78 (4.79 to 9.58) 4.68 (3.24 to 6.74) 476 (67.04) 1.24 (1.03 to 1.49) 1.24 (1.00 to 1.54)
Over-the-counter purchase of non-prescription antibiotics in the past year <0.0001

 No 709 (42.66) 55 (11.90) Reference Reference 251 (35.35) Reference Reference
 Yes 953 (57.34) 407 (88.10) 5.51 (4.09 to 7.42) 3.21 (2.34 to 4.41) 459 (64.65) 1.36 (1.13 to 1.63) 1.22 (0.99 to 1.51)
Sociodemographic characteristics
Age 1.03 (0.99 to 1.07) 1.01 (0.97 to 1.05) 0.99 (0.96 to 1.02) 0.99 (0.95 to 1.03)
Sex 0.19

 Male 876 (52.71) 243 (52.60) Reference Reference 357 (50.28) Reference Reference
 Female 786 (47.29) 219 (47.40) 1.00 (0.82 to 1.23) 1.22 (0.97 to 1.52) 353 (49.72) 1.10 (0.92 to 1.31) 1.12 (0.92 to 1.35)
Urbanicity of home town 0.64

 Rural 1000 (60.17) 273 (59.09) Reference Reference 371 (52.25) Reference Reference
 Urban 662 (39.83) 189 (40.91) 1.05 (0.85 to 1.29) 1.07 (0.83 to 1.39) 339 (47.75) 1.38 (1.16 to 1.65) 1.11 (0.89 to 1.38)
Average household income (¥, monthly) 0.14


 >10 000 (>$1538) 307 (18.47) 83 (17.97) Reference Reference 106 (14.93) Reference Reference
 3001–10 000 ($462–$1538) 907 (54.57) 239 (51.73) 0.97 (0.74 to 1.29) 0.82 (0.60 to 1.12) 357 (50.28) 1.14 (0.89 to 1.47) 1.07 (0.82 to 1.41)
 ≤3000 ($461) 448 (26.96) 140 (30.30) 1.16 (0.85 to 1.57) 0.97 (0.67 to 1.41) 247 (34.79) 1.60 (1.22 to 2.09) 1.37 (0.99 to 1.89)
Self-efficacy for healthcare decisions
Major in medicine 0.03

 No 1365 (82.13) 397 (85.93) Reference Reference 634 (89.30) Reference Reference
 Yes 297 (17.87) 65 (14.07) 0.75 (0.56 to 1.01) 0.89 (0.64 to 1.25) 76 (10.70) 0.55 (0.42 to 0.72) 0.68 (0.50 to 0.91)
Having at least one parent with medical background 0.34

 No 1488 (89.53) 395 (85.50) Reference Reference 641 (90.28) Reference Reference
 Yes 174 (10.47) 67 (14.50) 1.45 (1.07 to 1.96) 1.27 (0.91 to 1.78) 69 (9.72) 0.92 (0.69 to 1.23) 1.00 (0.72 to 1.37)
Region (University, Province) <0.0001





 North (NKU, Tianjin) 276 (16.61) 81 (17.53) Reference Reference 60 (8.45) Reference Reference
 East (ZJU, Zhejiang) 310 (18.65) 38 (8.23) 0.42 (0.27 to 0.63) 0.50 (0.32 to 0.79) 111 (15.63) 1.65 (1.16 to 2.35) 1.86 (1.27 to 2.73)
 Southwest (GZU, Guizhou) 240 (14.44) 84 (18.18) 1.19 (0.84 to 1.69) 0.98 (0.66 to 1.44) 169 (23.80) 3.24 (2.30 to 4.56) 2.49 (1.72 to 3.60)
 Northwest (LZU, Gansu) 287 (17.27) 103 (22.29) 1.22 (0.88 to 1.71) 1.08 (0.75 to 1.56) 138 (19.44) 2.21 (1.57 to 3.12) 1.92 (1.33 to 2.77)
 South (WHU, Hubei) 297 (17.87) 50 (10.82) 0.57 (0.39 to 0.85) 0.66 (0.43 to 1.00) 133 (18.73) 2.06 (1.46 to 2.91) 2.39 (1.66 to 3.45)
 Northeast (JLU, Jilin) 252 (15.16) 106 (22.94) 1.43 (1.02 to 2.01) 1.10 (0.76 to 1.60) 99 (13.94) 1.81 (1.26 to 2.60) 1.37 (0.93 to 2.03)

*Likelihood ratio tests for treatment decisions for URTIs.

†Adjusted for age, sex, household income, urbanicity, university major in medicine, having at least one parent with medical background and region/province.

‡Bold values denote statistical significance at the p < 0.05 level.

AMR, antimicrobial resistance; aRRR, adjusted relative risk ratio; RRR, relative risk ratio.